bi-featured

Shift Happens: Embrace the Change, Lead the Way

Shift Happens: Embrace the Change, Lead the WayShift Happens: Embrace the Change, Lead the Way Nick Tasler, Author, helps you figure out what change means for you and your company [video].

Panel - Don’t Fear the Future

Don’t Fear the Future: A Discussion About the Challenges and Opportunities AheadA Discussion About the Challenges and Opportunities Ahead In a panel moderated by Dr. John Waddell (Boehringer Ingelheim Vetmedica, Senior Professional Services Veterinarian), Dr. Dave Bomgaars (President at RC Family Farms and Orange City Veterinary Clinic), Dr. Jim Lowe (Associate Professor and Director of the i-Learning Center, College of Veterinary Medicine at the University of Illinois), and Bill Davis (Boehringer Ingelheim Director of Government Affairs) discuss the issues of critical importance today with the pork industry and thoughts on the future [video].

IAV-S Control: Reminders of What Made Whole Herd Approach (WHA) a Success

Tech Talk – IAV-S Control: Reminders of What Made Whole Herd Approach (WHA) a SuccessTech Talk – IAV-S Control: Reminders of What Made Whole Herd Approach (WHA) a Success Dr. Christa Goodell, Boehringer Ingelheim, shares information on IAV-S control and reminds us of what made the Whole Herd Approach a success [video].

The D.C. Download: An Update on Government Regulations

The D.C. Download: An Update on Government RegulationsUpdates on Government Regulations and Future Elections Bill Davis, Boehringer Ingelheim Director of Government Affairs, reviews the 2018 election activity, impacts on regulation and policy, and what it might mean for the 2020 election [video].

Economic & Production Benefit of 2 PRRS MLV Doses

Tech Talk –  Economic & Production Benefit of 2 PRRS MLV Doses Compared to a Single Dose Vaccination Program in Growing PigsTech Talk – Economic & Production Benefit of 2 PRRS MLV Doses Compared to a Single Dose Vaccination Program in Growing Pigs Dr. Cesar A.A. Moura, Veterinary Diagnostic and Production Animal Medicine, Iowa State University, shares research and analysis on the production and economic benefit of 2 PRRS MLV doses compared to a single dose vaccination program on growing pigs. [video].

Fact vs. Fiction – PCV3 Unraveled

Tech Talk – Fact vs. Fiction – PCV3 Unraveled Tech Talk – Fact vs. Fiction – PCV3 Unraveled Dr. Eduardo Fano, Boehringer Ingelheim, updates us on PCV3, and highlights facts versus myths. Some key observations: 1) PCV3 is widespread in the U.S. and co-infections with PCV2 and PRRSV are commonly found in PCV3 samples, 2) Clinical association: PDNS, Multi-systemic, reproductive failure, PRDC and tremors, and 3) Reproductive Failure has been the most consistent clinical association [video].

Effects and Costs of Swine Respiratory Diseases

Porcine Respiratory Disease ComplexUnderstanding Porcine Respiratory Disease Complex Dr. Christa Goodell, Technical Manager, Boehringer Ingelheim Vetmedica, Inc., and Dr. Reid Philips, PRRS Senior Technical Manager, Boehringer Ingelheim, provides insight on the impact and costs of porcine respiratory diseases like Porcine Respiratory Disease Complex (PRDC), Porcine Reproductive And Respiratory Syndrome virus (PRRSv), and Influenza A Virus in Swine (IAV-S). Drs. Goodell and Philips outline approaches to diagnosis, treatment, and prevention within swine operations [video].

Boehringer Ingelheim Science In Practice Reception

Science In Practice ReceptionScience In Practice Reception Boehringer Ingelheim remembered Dr. Bob Morrison in their pre-Allen D. Leman Conference Science In Practice Reception. Additionally, Dr. Bob Thompson, PIC, received the the Science in Practice Award [video].

Comparison of Intestinal Lesions

Comparison of intestinal lesions between Enterisol® Ileitis and Porcilis® Ileitis using a Lawsonia intracellularis mucosal homogenate seeder pig challenge modelComparison of intestinal lesions between Enterisol® Ileitis and Porcilis® Ileitis using a Lawsonia intracellularis mucosal homogenate seeder pig challenge model Dr. Jessica Seate, Boehringer Ingelheim Vetmedica, Inc, presents research on a comparison of intestinal lesions between Enterisol® Ileitis and Porcilis® Ileitis using a Lawsonia intracellularis mucosal homogenate seeder pig challenge model. Dr. Seate concludes with a summary that shares that IHC scores and histologic lesions (H&E) were lower for Enterisol® Ileitis group compared to the Porcilis® Ileitis and NVC groups, Enterisol® Ileitis had lowest percentage of PCR positives at necropsy, and IgG Lawsonia ELISA titers are not indicative of protective immunity [video].

Efficacy of Ingelvac PRRS® MLV

Efficacy of Ingelvac PRRS® MLV against a heterologous PRRSV 1-7-4 RFLP challengeEfficacy of Ingelvac PRRS® MLV against a heterologous PRRSV 1-7-4 RFLP challenge Dr. Reid Philips, Boehringer Ingelheim Vetmedica, Inc, shares insights on the efficacy of Ingelvac PRRS® MLV against a heterologous PRRSV 1-7-4 RFLP challenge. Key findings include: Ingelvac PRRS® MLV demonstrated significant protection against a virulent PRRSv ‘174’ challenge: 1) Significant reduction in viremia, 2) Significant reduction in lung lesions, and 3) Significant improvement in Daily Gain. Also, Ingelvac PRRS® MLV continues to demonstrate cross protection against new-emerging field strains [video].
Syndicate content